Cancer News and Research

Latest Cancer News and Research

Researchers identify potentially treatable subtype of pancreatic cancer

Researchers identify potentially treatable subtype of pancreatic cancer

Patients who receive automated telephone calls are more likely to have controlled hypertension

Patients who receive automated telephone calls are more likely to have controlled hypertension

Gentris expands genomic biomarker offering with launch of Affymetrix GeneChip HTA services

Gentris expands genomic biomarker offering with launch of Affymetrix GeneChip HTA services

First generic version of Xeloda gets FDA approval for breast and colorectal cancers

First generic version of Xeloda gets FDA approval for breast and colorectal cancers

New "app" from Henry Ford for cancer surgery patients

New "app" from Henry Ford for cancer surgery patients

Research: Immature sugar molecules aid growth properties of cancer cells

Research: Immature sugar molecules aid growth properties of cancer cells

Gene panel predicts low-risk prostate cancer fate

Gene panel predicts low-risk prostate cancer fate

Gene variations predict breast cancer sleep disturbance

Gene variations predict breast cancer sleep disturbance

Bruker Launches Second Phase Of SISCAPA-MALDI Collaboration

Bruker Launches Second Phase Of SISCAPA-MALDI Collaboration

Smoking-cessation in HIV-positive individuals: an interview with Dr Ellen R. Gritz, University of Texas MD Anderson Cancer Center

Smoking-cessation in HIV-positive individuals: an interview with Dr Ellen R. Gritz, University of Texas MD Anderson Cancer Center

Affimed Therapeutics, LLS partner to co-fund AFM13 phase 2 trial for treatment of Hodgkin Lymphoma

Affimed Therapeutics, LLS partner to co-fund AFM13 phase 2 trial for treatment of Hodgkin Lymphoma

ISA Pharmaceuticals announces initiation of ISA101 Phase I/II trial in HIV-positive men with AIN

ISA Pharmaceuticals announces initiation of ISA101 Phase I/II trial in HIV-positive men with AIN

Relmada Therapeutics collaborates with the Malvern Consulting Group

Relmada Therapeutics collaborates with the Malvern Consulting Group

First Edition: September 16, 2013

First Edition: September 16, 2013

Women's faith in God helps them cope with breast cancer

Women's faith in God helps them cope with breast cancer

Speed Queen partners with BCRF to support search for breast cancer cure

Speed Queen partners with BCRF to support search for breast cancer cure

Kinder chemistry promises cleaner and safer pharmaceuticals with fewer side-effects

Kinder chemistry promises cleaner and safer pharmaceuticals with fewer side-effects

Study: Opioid prescribing for non-cancer pain increases

Study: Opioid prescribing for non-cancer pain increases

New approach subtypes cancers by shared genetic effects; a step toward personalized medicine

New approach subtypes cancers by shared genetic effects; a step toward personalized medicine

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.